Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Lexaria Bioscience (LEXX) stocks in Canada

Learn how to easily invest in Lexaria Bioscience stocks.

Lexaria Bioscience is a biotechnology business based in the US. Lexaria Bioscience stocks (LEXX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.714 – an increase of 1.95% over the previous week. Lexaria Bioscience employs 6 staff and has a trailing 12-month revenue of around $440,962.

How to buy shares in Lexaria Bioscience

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LEXX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Lexaria Bioscience stock price (NASDAQ:LEXX)

Use our graph to track the performance of LEXX stocks over time.

Lexaria Bioscience shares at a glance

Information last updated 2022-01-18.
Latest market close$4.70
52-week range$3.78 - $12.50
50-day moving average $5.03
200-day moving average $5.93
Wall St. target price$12.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.05

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Lexaria Bioscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Lexaria Bioscience price performance over time

Historical closes compared with the close of $4.7 from 2022-01-20

1 week (2022-01-13) 6.58%
1 month (2021-12-17) N/A
3 months (2021-10-21) -30.68%
6 months (2021-07-21) -44.31%
1 year (2021-01-21) 8.55%
2 years (2020-01-21) 885.95%
3 years (2019-01-18) 219.73%
5 years (2017-01-20) 770.37%

Lexaria Bioscience financials

Revenue TTM $440,962
Gross profit TTM $547,392
Return on assets TTM -62.65%
Return on equity TTM -105%
Profit margin 0%
Book value $2.04
Market capitalisation $27.4 million

TTM: trailing 12 months

Lexaria Bioscience share dividends

We're not expecting Lexaria Bioscience to pay a dividend over the next 12 months.

Have Lexaria Bioscience's shares ever split?

Lexaria Bioscience's shares were split on a 1:30 basis on 11 January 2021. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lexaria Bioscience shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Lexaria Bioscience shares which in turn could have impacted Lexaria Bioscience's share price.

Lexaria Bioscience share price volatility

Over the last 12 months, Lexaria Bioscience's shares have ranged in value from as little as $3.779 up to $12.5. A popular way to gauge a stock's volatility is its "beta".

LEXX.US volatility(beta: 1.82)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lexaria Bioscience's is 1.8155. This would suggest that Lexaria Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Lexaria Bioscience overview

Lexaria Bioscience Corp. , a biotechnology company, operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology that improves the delivery of bioactive compounds that promotes healthy ingestion methods, lowers overall dosing, and higher effectiveness in active molecule delivery. The company serves various companies in CBD and nutraceuticals industries. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site